Business News

India’s largest steel producer is slowing down production when Covid problems hit


India’s largest steel producer expects to be overwhelmed by the country’s brutality second wave of coronavirus lasts until September as it reduces production due to air pollution and declining industrial demand.

JSW is also struggling to vaccinate co-workers, allies and their families, who together have about 1m in the community, as the country struggles to cope with the shortage of jabs.

The company, India’s largest metal producer in the Rs1.8tn ($ 24.4bn) market, has cut steel by about 10%, JSW billion billionaire chairman Sajjan Jindal told the Financial Times.

Covid-19 hyperactivity deficits force industry sales teams to transfer air from factories to hospitals.

The JSW cuts show how the second wave of India is hurting what is sometimes supposed to be profitable for Indian companies.

The economy and consumer demand are expected to return after a reduction in the coronavirus last year, while steelmakers had a strong outlook on the global market.

Sajjan Jindal, chair of JSW, India’s largest metal producer © Bloomberg

India Corporate needs to deal with oxygen shortages and vaccinations, high unemployment rates and disease. Other companies, including major car manufacturer Maruti Suzuki, are cutting production and temporarily closing factories.

“I never imagined there could be a second wave that could be so violent and so dangerous,” said Jindal, one of India’s strongest. “We see this clearly [on domestic demand] coming to our company. . . I see confusion until September. ”

India has announced more than 400,000 Covid-19 and 4,000 deaths on Saturday, though experts believe real interest rates are too high.

Advertisers remain confident in JSW, whose share has grown by 90% since the beginning of this year, thanks to global steel markets.

Jindal said JSW could repay lower mortgage loans, which make up about one-fifth of the total revenue. “The global iron ore has turned north and JSW is recovering well,” said Saurabh Mukherjea, founder of Marcellus Investment Managers.

But at home the image remains a challenge due to the deterioration of business and the problem that the disease is inflicting on companies and their employers.

JSW is now the largest supplier of liquid medicine in the country, according to Jindal, which delivers about 1,200 tons per day. He said he expected this to continue for “a few months”.

The company also faced the challenge of caring for employees and their relatives.

Legislative changes this month allow companies to try to inject active vaccines through liaison with private hospitals, but JSW – like many others – has failed to find jabs due to the crisis. Lack of vaccination this is expected to continue until July.

He also said that about 20 to 30 employees are tested by Covid-19 daily at the company’s production facility in Ballari in southern India.

“We as a country have failed to vaccinate,” Jindal said. “We were able. Somehow, I don’t know, we didn’t see it as very important. ”

He also said that the authorities would have prepared the country for the second wave, although he said no one expected it to be difficult.

“We were very disruptive in the preparation of this wave,” he said. “Otherwise we would not have elections, we would not have Kumbh,” he said, referring to the local elections and the religious rally that was held during the trial.

“We would be very careful about this. We have lost many lives and we continue to lose many lives. ”


Source link

Related Articles

Leave a Reply

Back to top button